Literature DB >> 19319964

A comparative biochemical analysis of glycosaminoglycans and proteoglycans in human orthotopic and heterotopic bone.

Vassiliki M Mania1, Alkiviadis G Kallivokas, Christina Malavaki, Athanasia P Asimakopoulou, John Kanakis, Achilleas D Theocharis, George Klironomos, George Gatzounis, Athanasia Mouzaki, Elias Panagiotopoulos, Nikos K Karamanos.   

Abstract

Glycosaminoglycans and proteoglycans are macromolecules of the bone and are involved in the assembly, maturation, mineralization, and maintenance of the extracellular matrix. Heterotopic ossification is the rapid development of calcified bone tissue at ectopic sites of the body, mainly in soft tissues that normally do not ossify. The aim of this study was to characterize the molecular profiles of glycosaminoglycans and proteoglycans in normal and heterotopic bone samples to assess whether differences exist between orthotopic and heterotopic bone. Heterotopic bone tissues contained lower amounts of glycosaminoglycans compared to normal femoral bone. Structural analysis of chondroitin sulfate (CS) revealed that both heterotopic and normal femoral bones were composed mainly of 6-sulfated disaccharides. Quantitative differences in the disaccharide composition of CS, such as the decrease of 6-sulfated disaccharides in heterotopic bone with a concurrent increase of 4-sulfated and nonsulfated disaccharides, were found between ectopic bone and normal femoral bone. The proteoglycans decorin and aggrecan were both detected in all bone samples using specific antibodies. The detection of minor amounts of aggrecan in mature human bone, such as femoral bone, as well as in ectopic bone is described for the first time. These results may elucidate the phenomenon of ectopic bone formation and assist in early detection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319964     DOI: 10.1002/iub.167

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  7 in total

1.  Myositis ossificans in children: a review.

Authors:  N K Sferopoulos; R Kotakidou; A S Petropoulos
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-03-09

Review 2.  Regenerative potential of glycosaminoglycans for skin and bone.

Authors:  Juliane Salbach; Tilman D Rachner; Martina Rauner; Ute Hempel; Ulf Anderegg; Sandra Franz; Jan-Christoph Simon; Lorenz C Hofbauer
Journal:  J Mol Med (Berl)       Date:  2011-12-21       Impact factor: 4.599

3.  Effects of chrondro-osseous regenerative compound associated with local treatments in the regeneration of bone defects around implants: an in vivo study.

Authors:  André Tonetto; Pablo Walker Lago; Márcia Borba; Vinícius Rosa
Journal:  Clin Oral Investig       Date:  2015-06-17       Impact factor: 3.573

Review 4.  Methods for isolating and analyzing physiological hyaluronan: a review.

Authors:  Felipe Rivas; Dorothea Erxleben; Ian Smith; Elaheh Rahbar; Paul L DeAngelis; Mary K Cowman; Adam R Hall
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-23       Impact factor: 4.249

5.  Buoyancy-Driven Gradients for Biomaterial Fabrication and Tissue Engineering.

Authors:  Chunching Li; Liliang Ouyang; Isaac J Pence; Axel C Moore; Yiyang Lin; Charles W Winter; James P K Armstrong; Molly M Stevens
Journal:  Adv Mater       Date:  2019-03-07       Impact factor: 30.849

6.  Artificial extracellular matrices with oversulfated glycosaminoglycan derivatives promote the differentiation of osteoblast-precursor cells and premature osteoblasts.

Authors:  Ute Hempel; Carolin Preissler; Sarah Vogel; Stephanie Möller; Vera Hintze; Jana Becher; Matthias Schnabelrauch; Martina Rauner; Lorenz C Hofbauer; Peter Dieter
Journal:  Biomed Res Int       Date:  2014-04-28       Impact factor: 3.411

7.  Heterotopic ossification in a patient with diffuse idiopathic skeletal hyperostosis: Input from histological findings.

Authors:  Caterina Licini; Luca Farinelli; Giorgia Cerqueni; Andrell Hosein; Saverio Marchi; Antonio Gigante; Monica Mattioli-Belmonte
Journal:  Eur J Histochem       Date:  2020-12-03       Impact factor: 3.188

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.